journal
https://read.qxmd.com/read/38579289/pembrolizumab-associated-anti-mda5-dermatomyositis-in-a-patient-with-lung-cancer-a-first-case-report
#21
JOURNAL ARTICLE
Antonino Marcello Pilia, Lorenzo Salvati, Alessia Guidolin, Francesca Mazzoni, Lorenzo Antonuzzo, Paola Parronchi, Francesco Liotta
We report the first case of anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis as a systemic immune-related adverse event in a 64-year-old man receiving pembrolizumab to treat advanced lung cancer. The patient experienced hypothyroidism, myalgia, skin involvement, dyspnoea and diarrhoea. Laboratory tests revealed raised inflammatory markers, hypercreatinekinasemia and anti-MDA5 autoantibodies. Electroneuromyography and pathognomonic signs on physical examination confirmed the diagnosis of pauci-myopathic dermatomyositis...
March 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579293/hepatitis-c-prevalence-and-cascade-of-care-among-patients-in-the-decentralised-opioid-agonist-therapy-programme-of-the-canton-of-st-gallen-switzerland-a-cross-sectional-study
#22
JOURNAL ARTICLE
Kerstin Wissel, Pietro Vernazza, Stefan Kuster, Katharina Hensel-Koch, Andrea Bregenzer
BACKGROUND: To eliminate chronic hepatitis C virus (HCV) infection by 2030, 90% of those infected must be diagnosed and 80% treated. In Switzerland, >40% of the estimated 32,000 infected people are still undiagnosed. In the canton of St Gallen, HCV prevalence and cascade of care have only been studied in the centralised opioid agonist therapy (OAT) setting (institutions), although about 80% of OAT patients are treated decentrally (general practitioner [GP] or pharmacy). AIM: To describe HCV prevalence and cascade of care among patients in the decentralised OAT programme of the canton of St Gallen, Switzerland, and compare it to contemporaneous data from the centralised setting...
February 29, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579297/the-magnitude-of-the-plasma-hepcidin-response-to-oral-iron-supplements-depends-on-the-iron-dosage
#23
JOURNAL ARTICLE
Maximilian Karczewski, Stana Simic, Lanja Saleh, Albina Nowak, Morton G Schubert, Diego Moretti, Dorine W Swinkels, Felix Beuschlein, Paolo M Suter, Pierre-Alexandre Krayenbuehl
BACKGROUND: Iron deficiency without anaemia is a common health problem, especially in young menstruating women. The efficacy of the usually recommended oral iron supplementation is limited due to increased plasma hepcidin concentration, which reduces iron absorption and leads to side effects such as intestinal irritation. This observation raises the question of how low-dose iron therapy may affect plasma hepcidin levels and whether oral iron intake dose-dependently affects plasma hepcidin production...
February 19, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579309/an-economic-evaluation-of-an-early-palliative-care-intervention-among-patients-with-advanced-cancer
#24
JOURNAL ARTICLE
Maud Maessen, Monica C Fliedner, Brigitta Gahl, Marina Maier, Daniel M Aebersold, Susanne Zwahlen, Steffen Eychmüller
BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interventions and the lack of information on the minimally effective dose for influencing care utilisation and costs, it remains uncertain whether early palliative care reduces costs. OBJECTIVES: We sought to determine whether an early palliative care intervention integrated in usual oncology care in a Swiss hospital setting reduced utilisation and costs of health care in the last month of life when compared with usual oncology care alone...
February 16, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579308/palliative-sedation-revised-recommendations
#25
JOURNAL ARTICLE
Michel Beauverd, Marta Mazzoli, Josiane Pralong, Martyna Tomczyk, Steffen Eychmüller, Jan Gaertner
Palliative sedation is defined as the monitored use of medications intended to induce a state of decreased or absent awareness (unconsciousness) to relieve the burden of otherwise intractable suffering in a manner ethically acceptable to the patient, their family, and healthcare providers. In Switzerland, the prevalence of continuous deep sedation until death increased from 4.7% in 2001 to 17.5% of all deceased in 2013, depending on the research method used and on regional variations. Yet, these numbers may be overestimated due to a lack of understanding of the term "continuous deep sedation" by for example respondents of the questionnaire-based study...
February 15, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579306/historic-characteristics-and-mortality-of-patients-in-the-swiss-amyloidosis-registry
#26
JOURNAL ARTICLE
Sofie Brouwers, Raphael Heimgartner, Natallia Laptseva, Adriano Aguzzi, Niklas F Ehl, Thomas Fehr, Felicitas Hitz, Hans H Jung, Joel Kälin, Markus G Manz, Beat Müllhaupt, Frank Ruschitzka, Harald Seeger, Georg Stussi, Markus Zweier, Andreas J Flammer, Bernhard Gerber, Rahel Schwotzer
AIMS OF THE STUDY: Systemic amyloidoses are rare protein-folding diseases with heterogeneous, often nonspecific clinical presentations. To better understand systemic amyloidoses and to apply state-of-the-art diagnostic pathways and treatment, the interdisciplinary Amyloidosis Network was founded in 2013 at University Hospital Zurich. In this respect, a registry was implemented to study the characteristics and life expectancy of patients with amyloidosis within the area covered by the network...
February 15, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579296/successful-treatment-of-immune-checkpoint-inhibitor-related-periaortitis
#27
JOURNAL ARTICLE
Elias D Bührer, Ian L Alberts, Lisa Christ, Berna C Özdemir
We report a 64-year-old patient with melanoma receiving ipilimumab and nivolumab therapy who presented with a periaortic soft tissue mass around the abdominal aorta on restaging fluorodeoxyglucose positron emission tomography/computed tomography imaging. Clinical, laboratory, and radiologic findings resulted in a diagnosis of immune checkpoint inhibitor-related periaortitis. Periaortitis is a rare disease presenting with fibro-inflammatory tissue around the aorta and may lead to serious complications. Immune checkpoint inhibitors were discontinued, and the patient was treated with glucocorticoids, leading to a complete resolution of the periaortitis...
February 15, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579324/therapeutic-management-of-fibrosis-in-systemic-sclerosis-patients-an-analysis-from-the-swiss-eustar-cohort
#28
JOURNAL ARTICLE
Kevin Windirsch, Suzana Jordan, Mike Oliver Becker, Cosimo Bruni, Rucsandra Dobrota, Muriel Elhai, Ion-Alexandru Garaiman, Carmen-Marina Mihai, Michele Iudici, Paul Hasler, Camillo Ribi, Britta Maurer, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler
OBJECTIVES: Systemic sclerosis is a chronic autoimmune connective tissue disease leading to microvascular and fibrotic manifestations in multiple organs. Several treatment options and recommendations from different European countries are available. In this study, for which the ambit is Switzerland specifically, we aim to describe the treatment patterns of systemic sclerosis patients with fibrotic manifestations. METHODS: Systemic sclerosis patients were selected from six Swiss tertiary centres recorded in the multicentre, prospective European Scleroderma Trials and Research (EUSTAR) registry...
February 6, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579322/changes-in-diagnostic-patterns-and-resource-utilisation-in-swiss-adult-icus-during-the-first-two-covid-19-waves-an-exploratory-study
#29
JOURNAL ARTICLE
Marco Previsdomini, Andreas Perren, Alessandro Chiesa, Mark Kaufmann, Hans Pargger, Roger Ludwig, Bernard Cerutti
BACKGROUND AND AIM: The coronavirus disease 2019 (COVID-19) outbreak deeply affected intensive care units (ICUs). We aimed to explore the main changes in the distribution and characteristics of Swiss ICU patients during the first two COVID-19 waves and to relate these figures with those of the preceding two years. METHODS: Using the national ICU registry, we conducted an exploratory study to assess the number of ICU admissions in Switzerland and their changes over time, characteristics of the admissions, the length of stay (LOS) and its trend over time, ICU mortality and changes in therapeutic nursing workload and hospital resources in 2020 and compare them with the average figures in 2018 and 2019...
February 5, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579298/use-of-metamizole-and-other-non-opioid-analgesics-in-switzerland-between-2014-and-2019-an-observational-study-using-a-large-health-insurance-claims-database
#30
JOURNAL ARTICLE
Stephan Gut, Marlene Rauch, Manuel Haschke, Carola A Huber, Jan Gaertner, Nadine Schur, Christoph R Meier, Julia Spoendlin
OBJECTIVE: To investigate claims patterns for metamizole and other non-opioid analgesics in Switzerland. To characterise users of these non-opioid analgesics regarding sex, age, comedications and canton of residence. METHODS: We conducted a retrospective descriptive study using administrative claims data of outpatient prescribed non-opioid analgesics of the Swiss health insurance company Helsana between January 2014 and December 2019. First, we evaluated the number of claims and defined daily doses  per year of metamizole, ibuprofen, diclofenac and paracetamol in adults aged 18 years or over...
February 5, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579303/prognostic-impact-of-carotid-plaque-imaging-using-total-plaque-area-added-to-score2-in-middle-aged-subjects-the-arteris-cardiovascular-outcome-arco-cohort-study
#31
JOURNAL ARTICLE
Michel Romanens, Ansgar Adams, Michel Wenger, Walter Warmuth, Isabella Sudano
AIMS: Many cardiovascular events occur in seemingly healthy individuals.We set out to assess the predictive value of atherosclerosis imaging in combination with cardiovascular risk calculators in subjects aged 40-65 years. METHODS: We compared PROCAM (PROspective CArdiovascular Münster study), SCORE (Systematic COronary Risk Evaluation) and SCORE2 with carotid ultrasound (total plaque area, TPA) in subjects without cardiovascular disease. In this prospective cohort study, follow-up was obtained by phone or mail from patients; or from clinical records, if needed...
January 25, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579329/what-are-the-bottlenecks-to-health-data-sharing-in-switzerland-an-interview-study
#32
JOURNAL ARTICLE
Kelly E Ormond, Sabine Bavamian, Claudia Becherer, Christine Currat, Francisca Joerger, Thomas R Geiger, Elke Hiendlmeyer, Julia Maurer, Timo Staub, Effy Vayena
BACKGROUND: While health data sharing for research purposes is strongly supported in principle, it can be challenging to implement in practice. Little is known about the actual bottlenecks to health data sharing in Switzerland. AIMS OF THE STUDY: This study aimed to assess the obstacles to Swiss health data sharing, including legal, ethical and logistical bottlenecks. METHODS: We identified 37 key stakeholders in data sharing via the Swiss Personalised Health Network ecosystem, defined as being an expert on sharing sensitive health data for research purposes at a Swiss university hospital (or a Swiss disease cohort) or being a stakeholder in data sharing at a public or private institution that uses such data...
January 22, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579311/stepwise-implementation-of-an-enhanced-recovery-pathway-for-elective-total-hip-arthroplasty-in-a-swiss-hospital-a-cohort-study
#33
JOURNAL ARTICLE
Simon Heinrich, Simon Gratza, Anke Eckardt, Thomas Ilchmann
BACKGROUND: Enhanced recovery programs after total hip arthroplasty have been shown to reduce hospital length of stay without compromising results, but yet there is a lack of data for the Swiss population. Therefore, this retrospective cohort study evaluated whether similar positive effects on clinical outcomes are present in the context of the Swiss healthcare system. METHODS: Patients who underwent elective primary total hip arthroplasty were analysed. The baseline group comprised 50 patients treated consecutively by one surgeon in 2013 according to the clinical practice guidelines...
January 22, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579330/who-was-at-risk-of-trauma-related-injuries-during-the-covid-19-pandemic-a-retrospective-study-from-a-level-1-trauma-centre-in-switzerland
#34
JOURNAL ARTICLE
Till Flury, Joël Gerber, Helen Anwander, Martin Müller, Dominik A Jakob, Aristomenis Exadaktylos, Karsten Klingberg
INTRODUCTION: During the first wave of the COVID-19 pandemic, increasingly strict restrictions were imposed on the activities of the Swiss population, with a peak from 21 March to 27 April 2020. Changes in trauma patterns during the pandemic and the lockdown have been described in various studies around the world, and highlight some particularly exposed groups of people. The objective of this study was to assess changes in trauma-related presentations to the emergency department (ED) during the first wave of the COVID-19 pandemic, as compared to the same period in the previous year, with a particular focus on vulnerable populations...
January 20, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579291/clinical-reasoning-for-the-continuation-or-discontinuation-of-hip-precautions-after-total-hip-arthroplasty-in-switzerland-a-qualitative-study
#35
JOURNAL ARTICLE
Jaroslaw Krygowski, Leah Reicherzer, Thimo Marcin
BACKGROUND: Growing evidence raises doubts about the need for routine hip precautions after primary total hip replacements to reduce the risk of postoperative dislocation. However, hip precautions are still routinely and widely prescribed in postoperative care in Switzerland. We aimed to investigate experts' clinical reasoning for hip precaution recommendations after total hip arthroplasty. METHODS: Using a convenience sampling strategy, 14 semi-structured expert interviews were conducted with surgeons, physiotherapists, and occupational therapists in the vicinity of an inpatient rehabilitation clinic in Switzerland...
January 4, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579316/influenza-transmission-dynamics-quantified-from-rna-in-wastewater-in-switzerland
#36
JOURNAL ARTICLE
Sarah Nadeau, Alexander J Devaux, Claudia Bagutti, Monica Alt, Evelyn Ilg Hampe, Melanie Kraus, Eva Würfel, Katrin N Koch, Simon Fuchs, Sarah Tschudin-Sutter, Aurélie Holschneider, Christoph Ort, Chaoran Chen, Jana S Huisman, Timothy R Julian, Tanja Stadler
INTRODUCTION: Influenza infections are challenging to monitor at the population level due to many mild and asymptomatic cases and similar symptoms to other common circulating respiratory diseases, including COVID-19. Methods for tracking cases outside of typical reporting infrastructure could improve monitoring of influenza transmission dynamics. Influenza shedding into wastewater represents a promising source of information where quantification is unbiased by testing or treatment-seeking behaviours...
January 3, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579295/perceptions-and-needs-of-an-outpatient-palliative-care-team-regarding-digital-care-conferences-in-palliative-care-a-mixed-method-online-survey
#37
JOURNAL ARTICLE
Andreas Samuel Ebneter, Maud Maessen, Thomas C Sauter, Georgette Jenelten, Steffen Eychmueller
BACKGROUND: Telemedicine in palliative care (PC) is increasingly being used, especially in outpatient settings with large geographic distances. Its proven benefits include improved communication, coordination quality and time savings. However, the effect on symptom control is less evident. Whether these benefits apply to the Swiss setting and the needs of healthcare professionals (HCPs) is unknown. OBJECTIVES: To identify the perceptions and needs of healthcare professionals (nurses and physicians) regarding telemedicine (generally and specifically for care conferences) in a Swiss outpatient palliative care network...
January 3, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38579325/long-term-course-of-neutralising-antibodies-against-sars-cov-2-in-vaccinated-and-unvaccinated-staff-and-residents-in-a-swiss-nursing-home-a-cohort-study-2021-2022
#38
JOURNAL ARTICLE
Lisa Perrig, Irene A Abela, Nicolas Banholzer, Annette Audigé, Selina Epp, Catrina Mugglin, Kathrin Zürcher, Matthias Egger, Alexandra Trkola, Lukas Fenner
BACKGROUND: Given their high-risk resident population, nursing homes were critical institutions in the COVID-19 pandemic, calling for continued monitoring and vaccine administration to healthcare workers and residents. Here, we studied long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunity in vaccinated and unvaccinated healthcare workers and residents of a nursing home in Switzerland between February 2021 and June 2022. METHODS: Our study comprised 45 participants, of which 39 were healthcare workers and six were residents...
December 22, 2023: Swiss Medical Weekly
https://read.qxmd.com/read/38579323/association-between-prehospital-physician-clinical-experience-and-discharge-at-scene-retrospective-cohort-study
#39
JOURNAL ARTICLE
Romain Betend, Laurent Suppan, Michele Chan, Simon Regard, François Sarasin, Christophe A Fehlmann
BACKGROUND: Clinical experience has been shown to affect many patient-related outcomes but its impact in the prehospital setting has been little studied. OBJECTIVES: To determine whether rates of discharge at scene, handover to paramedics and supervision are associated with clinical experience. DESIGN, SETTINGS AND PARTICIPANTS: A retrospective study, performed on all prehospital interventions carried out by physicians working in a mobile medical unit ("service mobile d'urgence et de réanimationˮ [SMUR]) at Geneva University Hospitals between 1 January 2010 and 31 December 2019...
December 20, 2023: Swiss Medical Weekly
https://read.qxmd.com/read/38579302/use-of-complementary-medicine-and-its-association-with-sars-cov-2-vaccination-during-the-covid-19-pandemic-a-longitudinal-cohort-study
#40
JOURNAL ARTICLE
Mayssam Nehme, Olivia Braillard, Pierre-Yves Rodondi, Idris Guessous
AIMS OF THE STUDY: Patients are increasingly using and requesting complementary medicine therapies, especially during the COVID-19 pandemic. However, it remains unclear whether they use them in conjunction with conventional medicine or to replace vaccination or other approaches and whether they discuss them with their physicians as part of shared decision-making. This study aimed to evaluate the use and initiation of complementary medicine during the COVID-19 pandemic, focusing on the association between complementary medicine use and COVID-19 vaccination status...
December 18, 2023: Swiss Medical Weekly
journal
journal
37164
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.